ProfileGDS4718 / 204576_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 67% 71% 82% 68% 63% 80% 80% 72% 68% 70% 70% 65% 75% 80% 80% 73% 74% 80% 82% 82% 66% 70% 72% 70% 67% 81% 67% 80% 71% 77% 80% 78% 61% 64% 82% 77% 76% 71% 70% 83% 74% 80% 82% 83% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.619367
GSM549102patient 115, normal, homogenized [OPG study]6.9330971
GSM549104patient 119, normal, homogenized [OPG study]8.1615982
GSM549108patient 138, normal, homogenized [OPG study]6.6854768
GSM549119patient 077, normal, homogenized [OPG study]6.3290763
GSM549133patient 032, cancer, homogenized [OPG study]7.956180
GSM549139patient 042, cancer, homogenized [OPG study]7.8974680
GSM549099patient 107, normal, homogenized [OPG study]6.9491172
GSM549109patient 139, normal, homogenized [OPG study]6.6726968
GSM549110patient 046, normal, homogenized [OPG study]6.847370
GSM549114patient 063, normal, homogenized [OPG study]6.8654270
GSM549122patient 082, normal, homogenized [OPG study]6.4717965
GSM549134patient 033, cancer, homogenized [OPG study]7.3243475
GSM549136patient 036, cancer, homogenized [OPG study]8.0064580
GSM549140patient 044, cancer, homogenized [OPG study]7.9904680
GSM549111patient 047, normal, homogenized [OPG study]7.2003473
GSM549113patient 057, normal, homogenized [OPG study]7.3093474
GSM549132patient 031, cancer, homogenized [OPG study]7.8439780
GSM549137patient 038, cancer, homogenized [OPG study]8.1319282
GSM549142patient 047, cancer, homogenized [OPG study]7.805582
GSM549100patient 110, normal, homogenized [OPG study]6.4904266
GSM549107patient 135, normal, homogenized [OPG study]6.8516370
GSM549115patient 068, normal, homogenized [OPG study]7.0985872
GSM549116patient 072, normal, homogenized [OPG study]6.8550970
GSM549120patient 078, normal, homogenized [OPG study]6.6166667
GSM549131patient 030, cancer, homogenized [OPG study]8.072681
GSM549118patient 074, normal, homogenized [OPG study]6.6733467
GSM549129patient 027, cancer, homogenized [OPG study]7.8382780
GSM549123patient 088, normal, homogenized [OPG study]6.9258771
GSM549124patient 006, cancer, homogenized [OPG study]7.5195777
GSM549126patient 015, cancer, homogenized [OPG study]7.8957780
GSM549128patient 025, cancer, homogenized [OPG study]7.6978678
GSM549103patient 117, normal, homogenized [OPG study]6.2093561
GSM549117patient 073, normal, homogenized [OPG study]6.3153264
GSM549138patient 041, cancer, homogenized [OPG study]8.0698682
GSM549141patient 045, cancer, homogenized [OPG study]7.648577
GSM549130patient 028, cancer, homogenized [OPG study]7.4343576
GSM549101patient 111, normal, homogenized [OPG study]6.9441571
GSM549105patient 128, normal, homogenized [OPG study]6.8895370
GSM549106patient 134, normal, homogenized [OPG study]8.373383
GSM549112patient 048, normal, homogenized [OPG study]7.1949574
GSM549125patient 011, cancer, homogenized [OPG study]7.8642680
GSM549127patient 024, cancer, homogenized [OPG study]8.0710282
GSM549135patient 035, cancer, homogenized [OPG study]8.2892383